Year Book of Ophthalmology 2015

1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. 1. Cataract Surgery - p. 7 5. A Prospective Randomized Clinical Evaluation of 3 Presbyopia-Correcting Intraocular Lenses After Cataract Extraction - p. 8 6. Comparison of near vision, intraocular lens movement, and depth of focus with accommodating and monofocal intraocular lenses - p. 9 7. Impact of Personality Characteristics on Patient Satisfaction After Multifocal Intraocular Lens Implantation: Results From the “Happy Patient Study” - p. 10 8. Multifocal Intraocular Lens Explantation: A Case Series of 50 Eyes - p. 11 9. Cortex Removal After Laser Cataract Surgery and Standard Phacoemulsification: A Critical Analysis of 800 Consecutive Cases - p. 12 10. Higher-Order Aberrations Associated With Better Near Visual Acuity in Eyes With Aspheric Monofocal IOLs - p. 13 11. The Impact on Vision of Aspheric to Spherical Monofocal Intraocular Lenses in Cataract Surgery: A Systematic Review with Meta-Analysis - p. 14 12. Using continuous intraoperative optical coherence tomography measurements of the aphakic eye for intraocular lens power calculation - p. 15 13. Achieving Target Refraction after Cataract Surgery - p. 16 14. Three-Year Incidence and Factors Associated With Posterior Capsule Opacification After Cataract Surgery: The Australian Prospective Cataract Surgery and Age-related Macular Degeneration Study - p. 17 15. Effect of total lens epithelial cell destruction on intraocular lens fixation in the human capsular bag - p. 18 16. Light transmittance of 1-piece hydrophobic acrylic intraocular lenses with surface light scattering removed from cadaver eyes - p. 19 17. Influence of Ocular Features and Incision Width on Surgically Induced Astigmatism After Cataract Surgery - p. 20 18. Post-cataract Prevention of Inflammation and Macular Edema by Steroid and Nonsteroidal Anti-inflammatory Eye Drops: A Systematic Review - p. 21 19. Incidence of postoperative endophthalmitis from 1990 to 2009 using povidone–iodine but no intracameral antibiotics at a single academic institution - p. 22 20. Intraocular Pressure and Wound Status in Eyes Immediately After Scleral Tunnel Incision and Clear Corneal Incision Cataract Surgery - p. 23 21. Increase in microbial contamination risk with compression of the lid margin in eyes having cataract surgery - p. 24 22. Lens-based glaucoma surgery: Using cataract surgery to reduce intraocular pressure - p. 25 23. Cataract Surgery in Patients with Fuchs' Endothelial Corneal Dystrophy: When to Consider a Triple Procedure - p. 26 24. Severe Bilateral Ischemic Retinal Vasculitis Following Cataract Surgery - p. 28 25. 2. Refractive Surgery - p. 29 26. Twenty-Year Follow-Up of a Randomized Prospective Clinical Trial of Excimer Laser Photorefractive Keratectomy - p. 30 27. The U.S. Army Surface Ablation Study: Comparison of PRK, MMC-PRK, and LASEK in Moderate to High Myopia - p. 31 28. Outcomes of Photorefractive Keratectomy Enhancement After LASIK - p. 32 29. Patient satisfaction and clinical outcomes with laser refractive surgery performed by surgeons in training - p. 33 30. Change in keratometry after myopic laser in situ keratomileusis and photorefractive keratectomy - p. 34 31. The Subject-Fixated Coaxially Sighted Corneal Light Reflex: A Clinical Marker for Centration of Refractive Treatments and Devices - p. 35 32. The Role of the Mesopic Pupil on Patient-Reported Outcomes in Young Patients With Myopia 1 Month After Wavefront-Guided LASIK - p. 36 33. Indications for and Outcomes of Tertiary Referrals in Refractive Surgery - p. 37 34. Corneal Sensation and Dry Eye Symptoms after Conventional versus Inverted Side-Cut Femtosecond LASIK: A Prospective Randomized Study - p. 38 35. Combination Therapy With Diquafosol Tetrasodium and Sodium Hyaluronate in Patients With Dry Eye After Laser In Situ Keratomileusis - p. 39 36. Variation in the effectiveness of refractive surgery during the year: Results from the Hamburg Weather Study - p. 40 37. Association Between the Percent Tissue Altered and Post–Laser In Situ Keratomileusis Ectasia in Eyes With Normal Preoperative Topography - p. 41 38. Five-year results of refractive lenticule extraction - p. 42 39. Safety and Complications of More Than 1500 Small-Incision Lenticule Extraction Procedures - p. 43 40. Small incision lenticule extraction (SMILE) and femtosecond laser LASIK: comparison of corneal wound healing and inflammation - p. 44 41. Differences in the Corneal Biomechanical Changes After SMILE and LASIK - p. 45 42. Comparison of biomechanical effects of small-incision lenticule extraction and laser in situ keratomileusis: Finite-element analysis - p. 46 43. Visual quality comparison of conventional and Hole-Visian implantable collamer lens at different degrees of decentering - p. 47 44. Comparative Study of 2 Types of Implantable Collamer Lenses, 1 With and 1 Without a Central Artificial Hole - p. 48 45. Orthokeratology-Associated Infectious Keratitis in a Tertiary Care Eye Hospital in Hong Kong - p. 49 46. 3. Cornea - p. 50 47. A Comparison of Lamellar and Penetrating Keratoplasty Outcomes: A Registry Study - p. 51 48. Endophthalmitis After Penetrating Keratoplasty - p. 52 49. Therapeutic and Optical Keratoplasty in the Management of Acanthamoeba Keratitis: Risk Factors, Outcomes, and Summary of the Literature - p. 53 50. Pneumodescemetopexy with perfluoroethane (C2F6) for the treatment of acute hydrops secondary to keratoconus - p. 54 51. Aganirsen Antisense Oligonucleotide Eye Drops Inhibit Keratitis-Induced Corneal Neovascularization and Reduce Need for Transplantation: The I-CAN Study - p. 55 52. Topical Cyclosporine in Corneal Transplantation - p. 56 53. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement - p. 57 54. Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study - p. 58 55. Medically Reversible Limbal Stem Cell Disease: Clinical Features and Management Strategies - p. 59 56. Collagen Cross-Linking with Photoactivated Riboflavin (PACK-CXL) for the Treatment of Advanced Infectious Keratitis with Corneal Melting - p. 60 57. Long-term Outcomes of Boston Type 1 Keratoprosthesis Implantation: A Retrospective Multicenter Cohort - p. 61 58. Therapeutic and Optical Keratoplasty in the Management of Acanthamoeba Keratitis: Risk Factors, Outcomes, and Summary of the Literature - p. 62 59. New Therapeutic Modality for Corneal Endothelial Disease Using Rho-Associated Kinase Inhibitor Eye Drops - p. 63 60. Ocular and Systemic Morbidity in a Longitudinal Cohort of Sjögren's Syndrome - p. 64 61. Treatment of pseudodendrites in herpes zoster ophthalmicus with topical ganciclovir 0.15% gel - p. 65 62. 4. Glaucoma - p. 66 63. New options for combined cataract and glaucoma surgery - p. 67 64. Sustained drug delivery in glaucoma - p. 68 65. Intraocular pressure fluctuation and glaucoma progression: what do we know? - p. 69 66. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine - p. 70 67. Teleglaucoma: ready to go? - p. 71 68. Clinical Outcomes in Cytomegalovirus-Positive Posner-Schlossman Syndrome Patients Treated With Topical Ganciclovir Therapy - p. 72 69. Three-year Treatment Outcomes in the Ahmed Baerveldt Comparison Study - p. 73 70. Increased risk of open-angle glaucoma following chronic rhinosinusitis: a population-based matched-cohort study - p. 74 71. Effect of Early Treatment with Aqueous Suppressants on Ahmed Glaucoma Valve Implantation Outcomes - p. 75 72. A Method to Estimate the Amount of Neuroretinal Rim Tissue in Glaucoma: Comparison With Current Methods for Measuring Rim Area - p. 76 73. Ocular hypertension: an approach to assessment and management - p. 77 74. Effect of Focal Lamina Cribrosa Defect on Glaucomatous Visual Field Progression - p. 78 75. Effectiveness of Intraocular Pressure–Lowering Medication Determined by Washout - p. 79 76. Glucose-Induced Temporary Visual Recovery in Primary Open-Angle Glaucoma: A Double-Blind, Randomized Study - p. 80 77. Examining Visual Field Loss in Patients in Glaucoma Clinics During Their Predicted Remaining Lifetime - p. 81 78. Is there a link between open-angle glaucoma and dementia? The Three-City–Alienor Cohort - p. 82 79. 5. Retina - p. 83 80. Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study: AREDS Report No. 36 - p. 84 81. Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials - p. 85 82. The Argus II Retinal Prosthesis: 12-Month Outcomes from a Single-Study Center - p. 86 83. The Neovascular Age-Related Macular Degeneration Database: Report 2: Incidence, Management, and Visual Outcomes of Second Treated Eyes - p. 87 84. Intravitreal Anti-Vascular Endothelial Growth Factor for Submacular Hemorrhage from Choroidal Neovascularization - p. 88 85. Outer retinal tubulation in the comparison of age-related macular degeneration treatment trails (CATT) - p. 89 86. Treat-and-Extend Bevacizumab for Neovascular Age-Related Macular Degeneration: The Importance of Baseline Characteristics - p. 90 87. Polymorphisms in Vascular Endothelial Growth Factor Receptor 2 Are Associated with Better Response Rates to Ranibizumab Treatment in Age-Related Macular Degeneration - p. 91 88. Intraocular Pressure in Eyes Receiving Monthly Ranibizumab in 2 Pivotal Age-Related Macular Degeneration Clinical Trials - p. 92 89. Subfoveal Choroidal Thickness as a Potential Predictor of Visual Outcome and Treatment Response After Intravitreal Ranibizumab Injections for Typical Exudative Age-Related Macular Degeneration - p. 93 90. Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration - p. 94 91. Safety of Intravitreal Ocriplasmin for Focal Vitreomacular Adhesion in Patients with Exudative Age-Related Macular Degeneration - p. 95 92. Baseline Choroidal Thickness as a Predictor for Response to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema - p. 96 93. Intravitreal Aflibercept for Diabetic Macular Edema - p. 97 94. Effect of combined cataract surgery and ranibizumab injection in postoperative macular edema in nonproliferative diabetic retinopathy - p. 98 95. Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion: Two-Year Results from the COPERNICUS Study - p. 99 96. Vitrectomy for Floaters: Prospective Efficacy Analyses and Retrospective Safety Profile - p. 100 97. 6. Uveitis - p. 101 98. The Future of Uveitis Treatment - p. 102 99. Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders - p. 103 100. Incidence of Visual Improvement in Uveitis Cases with Visual Impairment Caused by Macular Edema - p. 104 101. Risk for Uveitis With Oral Moxifloxacin: A Comparative Safety Study - p. 105 102. Tatto-Associated Uveitis - p. 106 103. The Value of Measuring Urinary β2-Microglobulin and Serum Creatinine for Detecting Tubulointerstitial Nephritis and Uveitis Syndrome in Young Patients With Uveitis - p. 107 104. Differential diagnosis of macular edema of different pathophysiologic origins by spectral domain optical coherence tomography - p. 108 105. Viral Retinitis following Intraocular or Periocular Corticosteroid Administration: A Case Series and Comprehensive Review of the Literature - p. 109 106. British Ocular Syphilis Study (BOSS): 2-Year National Surveillance Study of Intraocular Inflammation Secondary to Ocular Syphilis - p. 110 107. Characterisation of uveitis in association with multiple sclerosis - p. 111 108. 7. Oculoplastic Surgery - p. 112 109. Reduced Risk of Compressive Optic Neuropathy Using Orbital Radiotherapy in Patients With Active Thyroid Eye Disease - p. 113 110. Orbital Fractures and Ocular Injury: Is a Postoperative Ophthalmology Examination Necessary? - p. 114 111. High-Frequency Radiowave Electrosurgery for Persistent Conjunctival Chemosis Following Cosmetic Blepharoplasty - p. 115 112. Surgical Debulking for Idiopathic Dacryoadenitis: A Diagnosis and a Cure - p. 116 113. Patient and Physician Perceptions of Medicare Reimbursement Policy for Blepharoplasty and Blepharoptosis Surgery - p. 117 114. Glucocorticoid Regimens for Prevention of Graves' Ophthalmopathy Progression Following Radioiodine Treatment: Systematic Review and Meta-Analysis - p. 118 115. Serum selenium status in Graves' disease with and without orbitopathy: a case–control study - p. 119 116. Predicting the Need for Surgical Intervention in Pediatric Orbital Cellulitis - p. 120 117. Management of Functional Epiphora in Patients With an Anatomically Patent Dacryocystorhinostomy - p. 121 118. Elevated white blood cell count may predict risk of orbital implant exposure - p. 122 119. Bilateral Lacrimal Gland Disease: Clinical Features of 97 Cases - p. 123 120. Dynamic Changes of Tear Fluid After Cosmetic Transcutaneous Lower Blepharoplasty Measured by Optical Coherence Tomography - p. 124 121. Surgical Timing and Postoperative Ocular Motility in Type B Orbital Blowout Fractures - p. 125 122. The tarsal belt procedure for the correction of ectropion: description and outcome in 42 cases - p. 126 123. Botulinum Toxin Type A Injection for Lateral Canthal Rhytids: Effect on Tear Film Stability and Tear Production - p. 127 124. 8. Pediatric Ophthalmology - p. 128 125. Propranolol and Periocular Capillary Hemangiomas: Assessment of Refractive Effect - p. 129 126. Headache and Refractive Errors in Children - p. 130 127. Frequency of Choroidal Abnormalities in Pediatric Patients With Neurofibromatosis Type 1 - p. 131 128. Risk Factors for Amblyopia in the Vision in Preschoolers Study - p. 132 129. Outcomes of Strabismus Surgery with or without Trainee Participation as Surgeon - p. 133 130. Dual application versus single application of povidone-iodine in reducing surgical site contamination during strabismus surgery - p. 134 131. Treatment of age-related distance esotropia with unilateral lateral rectus resection - p. 135 132. Functional Burden of Strabismus: Decreased Binocular Summation and Binocular Inhibition - p. 136 133. Masked Bilateral Superior Oblique Palsy in Children - p. 137 134. Physician Use of White Coats in Pediatric Ophthalmology - p. 138 135. Surgical Outcomes Following Rectus Muscle Plication: A Potentially Reversible, Vessel-Sparing Alternative to Resection - p. 139 136. A Survey of Children's Reported Experience in Outpatient Pediatric Ophthalmology Clinics - p. 140 137. Comparison of Contact Lens and Intraocular Lens Correction of Monocular Aphakia During Infancy: A Randomized Clinical Trial of HOTV Optotype Acuity at Age 4.5 Years and Clinical Findings at Age 5 Years - p. 141 138. Fusion Maldevelopment (Latent/Manifest Latent) Nystagmus Syndrome: Effects of Four-Muscle Tenotomy and Reattachment - p. 142 139. Resident and Fellow Participation in Strabismus Surgery: Effect of Level of Training and Number of Assistants on Operative Time and Cost - p. 143 140. 9. Neuro-ophthalmology - p. 144 141. Effect of Disease Stage on Progression of Hydroxychloroquine Retinopathy - p. 145 142. Opportunistic Infections of the Retina in Patients With Aquaporin-4 Antibody Disease - p. 146 143. Microcystic Macular Edema: Retrograde Maculopathy Caused by Optic Neuropathy - p. 147 144. Marked Recovery of Vision in Children With Optic Pathway Gliomas Treated With Bevacizumab - p. 148 145. Safety and Effects of the Vector for the Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial - p. 149 146. Optic Neuropathy Induced by Experimentally Reduced Cerebrospinal Fluid Pressure in Monkeys - p. 150 147. Therapeutic Outcomes of High-Dose Intravenous Steroids in the Treatment of Dysthyroid Optic Neuropathy - p. 151 148. Factors associated with optic nerve sheath diameter during exposure to hypobaric hypoxia - p. 152 149. Prospective randomized trial of venous angioplasty in MS (PREMiSe) - p. 153 150. Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations - p. 154 151. Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS - p. 155 152. Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss: The Idiopathic Intracranial Hypertension Treatment Trial - p. 156 153. High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series - p. 157 154. Giant Cell Arteritis: Diagnostic Accuracy of MR Imaging of Superficial Cranial Arteries in Initial Diagnosis—Results from a Multicenter Trial - p. 158 155. Co-occurrence of Acute Retinal Artery Occlusion and Acute Ischemic Stroke: Diffusion-Weighted Magnetic Resonance Imaging Study - p. 159 156. Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players - p. 160 157. Clinical import of Horner syndrome in internal carotid and vertebral artery dissection - p. 161 158. Isolated Third, Fourth, and Sixth Cranial Nerve Palsies from Presumed Microvascular versus Other Causes: A Prospective Study - p. 162 159. Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial - p. 163 160. Education in medical billing benefits both neurology trainees and academic departments - p. 164 161. 10. Imaging - p. 165 162. Spontaneous Lateral Sphenoid Cephaloceles: Anatomic Factors Contributing to Pathogenesis and Proposed Classification - p. 166 163. Volumetric Assessment of Optic Nerve Sheath and Hypophysis in Idiopathic Intracranial Hypertension - p. 167 164. 11. Ocular Oncology - p. 168 165. Banning the Handshake From the Health Care Setting - p. 169 166. Iris stromal cyst management with absolute alcohol-induced sclerosis in 16 patients - p. 170 167. Proposed Lexicon for Anatomic Landmarks in Normal Posterior Segment Spectral-Domain Optical Coherence Tomography: The IN•OCT Consensus - p. 171 168. Plaque Radiotherapy for Juxtapapillary Choroidal Melanoma: Treatment Complications and Visual Outcomes in 650 Consecutive Cases - p. 172 169. Chromosome 3 Status Combined with BAP1 and EIF1AX Mutation Profiles is a Strong Prognostic Indicator for Uveal Melanoma - p. 173 170. Intra-arterial Chemotherapy for Retinoblastoma in 70 Eyes: Outcomes Based on the International Classification of Retinoblastoma - p. 174 171. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist - p. 175 172. Use of Topical Ice for Local Anesthesia for Intravitreal Injections - p. 176 173. Expanding the Clinical Phenotype of Hereditary BAP1 Cancer Predisposition Syndrome, Reporting Three New Cases - p. 177 174. Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma: A Randomized Clinical Trial - p. 178 175. 12. Pathology - p. 179 176. Eyelid Sebaceous Carcinoma: Clinicopathologic and Multiparametric Immunohistochemical Analysis That Includes Adipophilin - p. 180 177. Diagnostic Utility of Adipophilin Immunostain in Periocular Carcinomas - p. 181 178. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies - p. 183 179. A new rosette in retinoblastoma - p. 184 180. Histology of Müller′s muscle observed in quiescent Graves' orbitopathy - p. 185 181. Geographic Atrophy: A Histopathologic Assessment - p. 186 182. Retinal Cavernous Hemangioma: Fifty-Two Years of Clinical Follow-up With Clinicopathologic Correlation - p. 187 183. Choroidal Lymphoma: Clinical Features and Association with Systemic Lymphoma - p. 188 184. Usefulness of a Red Chromagen in the Diagnosis of Melanocytic Lesions of the Conjunctiva - p. 189 185. Effective Melanin Depigmentation of Human and Murine Ocular Tissues: An Improved Method for Paraffin and Frozen Sections - p. 190 186. Consensus Statement on the Immunohistochemical Detection of Ocular Lymphatic Vessels - p. 191 187. Immunophenotyping of Paucicellular Samples - p. 192